Preclinical in vivo assessment of 5-fluorouracil/cisplatin with and without dipyridamole against a human bladder tumor line: Correlation of tumor growth inhibition with host survival
Publication
, Journal Article
Keane, TE; Gingrich, JR; Rosner, G; Walther, PJ
Published in: Surgical Forum
December 1, 1990
Duke Scholars
Published In
Surgical Forum
ISSN
0071-8041
Publication Date
December 1, 1990
Volume
41
Start / End Page
696 / 698
Citation
APA
Chicago
ICMJE
MLA
NLM
Keane, T. E., Gingrich, J. R., Rosner, G., & Walther, P. J. (1990). Preclinical in vivo assessment of 5-fluorouracil/cisplatin with and without dipyridamole against a human bladder tumor line: Correlation of tumor growth inhibition with host survival. Surgical Forum, 41, 696–698.
Keane, T. E., J. R. Gingrich, G. Rosner, and P. J. Walther. “Preclinical in vivo assessment of 5-fluorouracil/cisplatin with and without dipyridamole against a human bladder tumor line: Correlation of tumor growth inhibition with host survival.” Surgical Forum 41 (December 1, 1990): 696–98.
Keane TE, Gingrich JR, Rosner G, Walther PJ. Preclinical in vivo assessment of 5-fluorouracil/cisplatin with and without dipyridamole against a human bladder tumor line: Correlation of tumor growth inhibition with host survival. Surgical Forum. 1990 Dec 1;41:696–8.
Keane, T. E., et al. “Preclinical in vivo assessment of 5-fluorouracil/cisplatin with and without dipyridamole against a human bladder tumor line: Correlation of tumor growth inhibition with host survival.” Surgical Forum, vol. 41, Dec. 1990, pp. 696–98.
Keane TE, Gingrich JR, Rosner G, Walther PJ. Preclinical in vivo assessment of 5-fluorouracil/cisplatin with and without dipyridamole against a human bladder tumor line: Correlation of tumor growth inhibition with host survival. Surgical Forum. 1990 Dec 1;41:696–698.
Published In
Surgical Forum
ISSN
0071-8041
Publication Date
December 1, 1990
Volume
41
Start / End Page
696 / 698